Valentyn Oksenych

4.0k total citations
108 papers, 2.1k citations indexed

About

Valentyn Oksenych is a scholar working on Molecular Biology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Valentyn Oksenych has authored 108 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Molecular Biology, 24 papers in Infectious Diseases and 20 papers in Epidemiology. Recurrent topics in Valentyn Oksenych's work include DNA Repair Mechanisms (22 papers), Gut microbiota and health (15 papers) and COVID-19 Clinical Research Studies (11 papers). Valentyn Oksenych is often cited by papers focused on DNA Repair Mechanisms (22 papers), Gut microbiota and health (15 papers) and COVID-19 Clinical Research Studies (11 papers). Valentyn Oksenych collaborates with scholars based in Norway, Ukraine and Iran. Valentyn Oksenych's co-authors include Frédéric Coin, Jean‐Marc Egly, Oleksandr Kamyshnyi, Frederick W. Alt, Pavlo Petakh, Denis E. Kainov, Magnar Bjørås, Iryna Kamyshna, Vipul Kumar and Chunguang Guo and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Valentyn Oksenych

100 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Valentyn Oksenych Norway 21 1.4k 364 310 249 200 108 2.1k
Hufeng Zhou United States 23 694 0.5× 584 1.6× 132 0.4× 309 1.2× 244 1.2× 38 1.5k
Joseph C. Devlin United States 15 807 0.6× 206 0.6× 226 0.7× 448 1.8× 135 0.7× 29 1.4k
Shihua He Canada 28 999 0.7× 191 0.5× 703 2.3× 180 0.7× 317 1.6× 70 2.0k
David H. Goetz United States 15 934 0.6× 183 0.5× 265 0.9× 332 1.3× 340 1.7× 17 2.7k
Pedro J. Beltran United States 25 953 0.7× 488 1.3× 141 0.5× 182 0.7× 115 0.6× 52 2.2k
Tianmin Xu China 27 1.3k 0.9× 370 1.0× 492 1.6× 372 1.5× 280 1.4× 96 2.6k
Qi Liang China 26 1.0k 0.7× 256 0.7× 339 1.1× 297 1.2× 282 1.4× 113 2.3k
Huabing Tan China 15 776 0.5× 524 1.4× 435 1.4× 443 1.8× 224 1.1× 30 2.1k
Priyanka Verma India 19 1.1k 0.8× 190 0.5× 276 0.9× 358 1.4× 268 1.3× 82 2.1k
Xiaofeng Li China 24 805 0.6× 141 0.4× 314 1.0× 458 1.8× 389 1.9× 166 1.9k

Countries citing papers authored by Valentyn Oksenych

Since Specialization
Citations

This map shows the geographic impact of Valentyn Oksenych's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Valentyn Oksenych with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Valentyn Oksenych more than expected).

Fields of papers citing papers by Valentyn Oksenych

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Valentyn Oksenych. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Valentyn Oksenych. The network helps show where Valentyn Oksenych may publish in the future.

Co-authorship network of co-authors of Valentyn Oksenych

This figure shows the co-authorship network connecting the top 25 collaborators of Valentyn Oksenych. A scholar is included among the top collaborators of Valentyn Oksenych based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Valentyn Oksenych. Valentyn Oksenych is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Беленичев, И. Ф., et al.. (2025). Targeting Mitochondrial Dysfunction in Cerebral Ischemia: Advances in Pharmacological Interventions. Antioxidants. 14(1). 108–108. 5 indexed citations
2.
Petakh, Pavlo, Valentyn Oksenych, & Oleksandr Kamyshnyi. (2025). Prevalence of leptospirosis among soldiers: A systematic review. PLoS neglected tropical diseases. 19(3). e0012927–e0012927. 1 indexed citations
3.
Shishkina, Svitlana V., et al.. (2025). Antistaphylococcal Triazole-Based Molecular Hybrids: Design, Synthesis and Activity. Pharmaceuticals. 18(1). 83–83. 2 indexed citations
5.
Arisawa, Mieko, et al.. (2025). In Silico Identification and Characterization of Spiro[1,2,4]triazolo[1,5-c]quinazolines as Diacylglycerol Kinase α Modulators. Molecules. 30(11). 2324–2324. 2 indexed citations
6.
Eslami, Majid, et al.. (2025). The Anti-Inflammatory Potential of Tricyclic Antidepressants (TCAs): A Novel Therapeutic Approach to Atherosclerosis Pathophysiology. Pharmaceuticals. 18(2). 197–197. 2 indexed citations
7.
Tahmasebi, Hamed, et al.. (2024). Microbiota and Cytokine Modulation: Innovations in Enhancing Anticancer Immunity and Personalized Cancer Therapies. Biomedicines. 12(12). 2776–2776. 20 indexed citations
8.
Petakh, Pavlo, et al.. (2024). Exploring the interplay between posttraumatic stress disorder, gut microbiota, and inflammatory biomarkers: a comprehensive meta-analysis. Frontiers in Immunology. 15. 1349883–1349883. 16 indexed citations
9.
Halabitska, Iryna, Pavlo Petakh, Oleh Lushchak, et al.. (2024). Metformin in Antiviral Therapy: Evidence and Perspectives. Viruses. 16(12). 1938–1938. 7 indexed citations
10.
Halabitska, Iryna, Pavlo Petakh, Iryna Kamyshna, et al.. (2024). The interplay of gut microbiota, obesity, and depression: insights and interventions. Cellular and Molecular Life Sciences. 81(1). 443–443. 19 indexed citations
11.
Petakh, Pavlo, Payam Behzadi, Valentyn Oksenych, & Oleksandr Kamyshnyi. (2024). Current treatment options for leptospirosis: a mini-review. Frontiers in Microbiology. 15. 1403765–1403765. 20 indexed citations
12.
Беленичев, И. Ф., et al.. (2024). Modulating Nitric Oxide: Implications for Cytotoxicity and Cytoprotection. Antioxidants. 13(5). 504–504. 31 indexed citations
14.
Halabitska, Iryna, Pavlo Petakh, Valentyn Oksenych, & Oleksandr Kamyshnyi. (2024). Predictive analysis of osteoarthritis and chronic pancreatitis comorbidity: complications and risk factors. Frontiers in Endocrinology. 15. 1492741–1492741. 4 indexed citations
15.
Oksenych, Valentyn, et al.. (2024). Genomic insight into COVID-19 severity in MAFLD patients: a single-center prospective cohort study. Frontiers in Genetics. 15. 1460318–1460318. 12 indexed citations
16.
Petakh, Pavlo, et al.. (2024). Comprehensive Analysis of Antiphage Defense Mechanisms: Serovar-Specific Patterns. Antibiotics. 13(6). 522–522. 2 indexed citations
17.
Oksenych, Valentyn, et al.. (2024). Exploring Paxlovid Efficacy in COVID-19 Patients with MAFLD: Insights from a Single-Center Prospective Cohort Study. Viruses. 16(1). 112–112. 6 indexed citations
18.
Yousefi, Bahman, et al.. (2024). Cefiderocol in Combating Carbapenem-Resistant Acinetobacter baumannii: Action and Resistance. Biomedicines. 12(11). 2532–2532. 9 indexed citations
19.
Беленичев, И. Ф., et al.. (2023). Altered Blood Molecular Markers of Cardiovascular Function in Rats after Intrauterine Hypoxia and Drug Therapy. Current Issues in Molecular Biology. 45(11). 8704–8715. 7 indexed citations
20.
Ianevski, Aleksandr, et al.. (2022). DrugVirus.info 2.0: an integrative data portal for broad-spectrum antivirals (BSA) and BSA-containing drug combinations (BCCs). Nucleic Acids Research. 50(W1). W272–W275. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026